Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bioavailability of two oral formulations of azithromycin 500 mg: a randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects.
Piñeyro-López A, Pineyro-Garza E, Torres-Alanís O, Reyes-Araiza R, Gómez Silva M, Wacksman N, Rangel RL, de Lago A, González-de la Parra M, Namur S. Piñeyro-López A, et al. Among authors: pineyro garza e. Clin Ther. 2005 Oct;27(10):1607-11. doi: 10.1016/j.clinthera.2005.10.002. Clin Ther. 2005. PMID: 16330296 Clinical Trial.
Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
Piñeyro-López A, Pineyro-Garza E, Torres-Alanís O, Reyes-Araiza R, Gómez Silva M, Wacksman N, Lujàn Rangel R, de Lago A, Trejo D, Gonzàlez-de la Parra M, Namur S. Piñeyro-López A, et al. Among authors: pineyro garza e. Clin Ther. 2006 Jan;28(1):110-5. doi: 10.1016/j.clinthera.2006.01.012. Clin Ther. 2006. PMID: 16490584 Clinical Trial.
Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers.
Piñeyro-López A, Piñeyro-Garza E, Torres-Alanís O, Reyes-Araiza R, Gómez-Silva M, Waksman N, E Salazar-Leal M, Luján-Rangel R. Piñeyro-López A, et al. Among authors: pineyro garza e. Clin Ther. 2007 Sep;29(9):2049-54. doi: 10.1016/j.clinthera.2007.09.004. Clin Ther. 2007. PMID: 18035203 Clinical Trial.
Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers.
Piñeyro-López A, Piñeyro-Garza E, Gómez-Silva M, Reyes-Araiza R, Flores-Diego MA, Borrego-Alvarado S, Gamino-Peña ME, Vargas-Zapata R, Salazar-Leal ME. Piñeyro-López A, et al. Among authors: pineyro garza e. Clin Ther. 2009 Feb;31(2):411-7. doi: 10.1016/j.clinthera.2009.02.001. Clin Ther. 2009. PMID: 19302913 Clinical Trial.
Application of Genomic Technologies in Clinical Pharmacology Research.
León-Cachón RB, Ascacio-Martínez JÁ, Gómez-Silva M, Piñeyro-Garza E, González-González JG, Pogue G, Simón-Buela L, Barrera-Saldaña HA. León-Cachón RB, et al. Among authors: pineyro garza e. Rev Invest Clin. 2015 Jul-Aug;67(4):212-8. Rev Invest Clin. 2015. PMID: 26426586 Free article. Review.
A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers.
León-Cachón RBR, Ascacio-Martínez JA, Gamino-Peña ME, Cerda-Flores RM, Meester I, Gallardo-Blanco HL, Gómez-Silva M, Piñeyro-Garza E, Barrera-Saldaña HA. León-Cachón RBR, et al. Among authors: pineyro garza e. BMC Cancer. 2016 Feb 8;16:74. doi: 10.1186/s12885-016-2062-2. BMC Cancer. 2016. PMID: 26857559 Free PMC article. Clinical Trial.
Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial.
Gómez-Silva M, Piñeyro-Garza E, Vargas-Zapata R, Gamino-Peña ME, León-García A, de León MB, Llerena A, León-Cachón RBR. Gómez-Silva M, et al. Among authors: pineyro garza e. Sci Rep. 2019 Nov 28;9(1):17833. doi: 10.1038/s41598-019-54436-z. Sci Rep. 2019. PMID: 31780765 Free PMC article. Clinical Trial.
Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study.
Poo JL, Aguilar JR, Bernal-Reyes R, Alonso-Campero R, Gasca F, Hernández L, Pineyro-Garza E, Gomez-Silva M, Gamino ME, la Parra MG, Peña P, Hernández N, Tapia G, Muñoz-Espinosa LE. Poo JL, et al. Among authors: pineyro garza e. Biomed Pharmacother. 2023 Dec;168:115712. doi: 10.1016/j.biopha.2023.115712. Epub 2023 Oct 21. Biomed Pharmacother. 2023. PMID: 37871556 Free article.